Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer | MicrobiomeTrials← Back to trialsNCT01084057
Ixabepilone and Vorinostat in Treating Patients With Metastatic Breast Cancer
CompletedPHASE1INTERVENTIONAL
Trial Details
Start: 2010-06-02Est. Completion: 2012-11-12
Enrollment target: 56 participants Locations- City of Hope, Duarte, California, United States
- South Pasadena Cancer Center, South Pasadena, California, United States
Other microbiome trials you might be interested in
Breast Cancer
This study will evaluate a podcast-based psychosocial support program for women who have been newly diagnosed with breas…
Multiple LocationsEst. completion Aug 1, 2027
Clear Cell Renal Cell CarcinomaStage IV Renal Cell Cancer AJCC v7
This randomized phase III trial studies how well pazopanib hydrochloride works compared to placebo in treating patients …
Fairbanks, United StatesEst. completion Jul 17, 2018
Phase 1
Recruiting
Breast NeoplasmsColorectal NeoplasmsProstate NeoplasmEndometrial NeoplasmsNeoplasm MetastasisStomach NeoplasmsEsophageal Neoplasms
The main purpose of this study is to evaluate safety, tolerability, and efficacy of LY4257496 alone and as part of relev…
Duarte, United StatesEst. completion Apr 2030